68 related articles for article (PubMed ID: 212566)
1. Nucleases and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in murine sarcoma virus (Moloney)-infected mice.
Tsou KC; Lo KW; Herberman RB
J Natl Cancer Inst; 1978 Oct; 61(4):1077-83. PubMed ID: 212566
[TBL] [Abstract][Full Text] [Related]
2. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
Ng AK; Ames RS; McIntire RK; Herberman RB
Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
[TBL] [Abstract][Full Text] [Related]
3. Effect of cadmium exposure on primary tumor growth and cell-mediated cytotoxicity in mice bearing MSB sarcomas.
Kerkvliet NI; Koller LD; Baecher LG; Brauner JA
J Natl Cancer Inst; 1979 Aug; 63(2):479-83. PubMed ID: 287837
[TBL] [Abstract][Full Text] [Related]
4. Cyclic 3',5'-adenosine monophosphate phosphodiesterase in the thymus of normal and leukemic mice.
Menahan LA; Kemp RG
J Cyclic Nucleotide Res; 1976; 2(6):417-25. PubMed ID: 190277
[TBL] [Abstract][Full Text] [Related]
5. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
McDonald TL
J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
[TBL] [Abstract][Full Text] [Related]
6. Effects of growth conditions on cyclic nucleotide phosphodiesterases of cultured fibroblasts.
Pledger WJ; Thompson J; Strada SJ
J Cyclic Nucleotide Res; 1975; 1(6):251-9. PubMed ID: 178699
[TBL] [Abstract][Full Text] [Related]
7. Croton oil- and benzo(a)pyrene-induced changes in cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate phosphodiesterase activities in mouse epidermis.
Verma AK; Froscio M; Murray AW
Cancer Res; 1976 Jan; 36(1):81-7. PubMed ID: 174815
[TBL] [Abstract][Full Text] [Related]
8. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors.
Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D
J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589
[TBL] [Abstract][Full Text] [Related]
9. Alteration of cellular ribonucleases associated with murine oncogenic virus infection.
Drake WP; Frazier LM; Sidle D; Mardiney MR
Biomedicine; 1978; 28(1):24-8. PubMed ID: 208672
[TBL] [Abstract][Full Text] [Related]
10. [Effect of irradiation and some sulfur containing compounds on 3':5'-cyclic AMP-phosphodiesterase activity of the tissue homogenates of experimental animals].
Zhivotova NI; Pushkareva NB; Filipovich IV; Romantsev EF
Radiobiologiia; 1975; 15(5):726-30. PubMed ID: 174148
[No Abstract] [Full Text] [Related]
11. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
12. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex.
Enjuanes L; Lee JC; Ihle JN
J Immunol; 1979 Feb; 122(2):665-74. PubMed ID: 84033
[No Abstract] [Full Text] [Related]
13. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
Becker S; Haskill S
J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
[TBL] [Abstract][Full Text] [Related]
14. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
White JB; Thompson WJ; Pittler SJ
Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
[TBL] [Abstract][Full Text] [Related]
15. Augmented immunogenicity of tumor cell membranes produced by infection with influenza virus as compared to Moloney sarcoma virus.
Takeichi N; Austin FC; Oikawa T; Boone CW
Cancer Res; 1978 Dec; 38(12):4580-4. PubMed ID: 214226
[TBL] [Abstract][Full Text] [Related]
16. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
[No Abstract] [Full Text] [Related]
17. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors.
Halliday WJ; Koppi TA; McKenzie IF
J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199
[TBL] [Abstract][Full Text] [Related]
18. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
Maurice DH
Cell Biochem Biophys; 1998; 29(1-2):35-47. PubMed ID: 9631237
[TBL] [Abstract][Full Text] [Related]
19. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
[TBL] [Abstract][Full Text] [Related]
20. Immune response to Moloney murine leukemia virus nonviral, tumor-associated antigens fails to provide in vivo tumor protection.
Jiang D; Flyer DC
J Immunol; 1992 Feb; 148(3):974-80. PubMed ID: 1730885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
